Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neuroblastoma 9Melanoma 4Ganglioneuroblastoma 4Triple Negative Breast Neoplasms 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 2Adenoma, Islet Cell 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Transplant-Related Hematologic Malignancy 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Alveolar Soft Part 1Recurrence 1Prostatic Neoplasms 1Pathologic Complete Response 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Locally Advanced Pancreatic Adenocarcinoma 1Leukemia, Plasma Cell 1Leukemia, Myeloid, Acute 1Leukemia 1Hodgkin Disease 1Gliosarcoma 1Glioblastoma 1Endometrial Neoplasms 1Carcinosarcoma 1Carcinoma, Transitional Cell 1

Interventions

spartalizumab 1sargramostim 1Taxes 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy 1Pancreaticoduodenectomy 1Magnetic Resonance Spectroscopy 1Laparoscopy 1Gemcitabine 1Drug Therapy 1Colony-Stimulating Factors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Pancreatic Adenocarcinoma × sargramostim × 1 year × Clear all
NCT00669734 2026-04-23

Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery

National Cancer Institute (NCI)

Phase 1 Active not recruiting
18 enrolled
Gastrointestinal

Locally Advanced Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡